Federal scientists finally publish remdesivir data

23 May 2020 - A clinical trial led to the authorisation of the only drug shown to work in COVID-19 patients. ...

Read more →

FDA launches new resource to provide easily accessible, more accurate historical drug approval data

21 February 2020 - FDA is launching a new resource to assist external and agency researchers collecting historical information about ...

Read more →

FDA launches mobile-friendly database with information on life-saving HIV drugs as part of ongoing mission to empower the public through increased access to information and data

29 January 2020 - Interactive tool offers information on ARVs eligible for purchase under the President’s Emergency Plan for AIDS Relief ...

Read more →

Will the FDA give the go-ahead to a prescription video game? The wait goes on, as new data come in.

21 January 2020 - In mid 2018, the startup Akili Interactive Labs asked the Food and Drug Administration to let ...

Read more →

FDA approves drugs faster than ever but relies on weaker evidence, researchers find

14 January 2020 - The FDA has gotten faster at approving new prescription drugs over the past four decades, but ...

Read more →

FDA real world evidence to be made available on Google Cloud

8 January 2020 - The company is making the agency's open-source MyStudies platform available, enabling for easier access to data for ...

Read more →

The challenges of sharing data in an era of politicised science

21 November 2019 - The goal of making science more transparent—sharing data, posting results on trial registries, use of preprint servers, ...

Read more →

10 year update on study results submitted to ClinicalTrials.gov

14 November 2019 - A decade after ClinicalTrials.gov launched a database for reporting results of clinical trials, the database includes results ...

Read more →

Google’s ‘Project Nightingale’ gathers personal health data on millions of Americans

11 November 2019 - Search giant is amassing health records from Ascension facilities in 21 states; patients not yet informed. ...

Read more →

In generic drug plants in China and India, data falsification is still a problem

29 October 2019 - As the generic drug industry faces allegations of data manipulation, headlines about carcinogen-tainted blood pressure medicine, ...

Read more →

FDA informs patients, providers and manufacturers about potential cybersecurity vulnerabilities for connected medical devices and health care networks that use certain communication software

1 October 2019 - Today, the U.S. FDA is informing patients, health care professionals, IT staff in health care facilities and ...

Read more →

Susan G. Komen Big Data for Breast Cancer Initiative: how patient advocacy organisations can facilitate using big data to improve patient outcomes

12 September 2019 - Integrating different types of data, including electronic health records, imaging data, administrative and claims databases, large data ...

Read more →

The startup that manipulated data to get a miracle drug to market

14 September 2019 - AveXis had a revolutionary gene therapy for babies with a deadly disease, and sold to Novartis for ...

Read more →

Reeling from scandal, Novartis vows to voluntarily release info on manipulated data in the future

9 September 2019 - Seeking to appease angry regulators, Novartis committed to notifying the FDA within five business days of ...

Read more →

FDA focuses on Novartis delay in reporting drug-test data manipulation

22 August 2019 - Regulators zeroing in on the company’s two-month delay in launching a formal inquiry. ...

Read more →